MJ Biz reports…
Eight of the 63 applications to admit products to Denmark’s medical cannabis trial scheme have won approval since the program’s inception in 2018, according to a recent disclosure by Health Minister Magnus Heunicke.Subsequently, however, four of the products were removed from the approved list because they could no longer be provided in the country of origin, Canada.Heunicke provided the new figures in an answer to a parliamentary query from Member of Parliament Jane Heitmann.
Approval and regulatory compliance in the origin country is a basic requirement for the admission of an imported cannabis product for the Danish scheme, Heunicke said in his answer.
That only 12% of products ultimately reached the Danish market so far is an example of the regulatory quagmire facing medical marijuana businesses in some countries.
Full Story
Denmark approved only eight of 63 medical cannabis product applications
